Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

TMED vs PHLAX overlap: 48% of top holdings shared

Bottom line

How much do TMED and PHLAX overlap?

48% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 37.6% of TMED's assets and 38.0% of PHLAX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

TMEDPHLAX
Weight overlap (top 25)48%
Shared holdings7
Weight in shared holdings37.6%38.0%
Total positions10255
Expense ratio0.44%1.15%
Holdings as ofJun 30, 2026May 29, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Holdings TMED and PHLAX have in common

Holding% of TMED% of PHLAXOverlap
Eli Lilly & Co16.71%17.35%16.71%
Unitedhealth Group Inc6.52%5.87%5.87%
Thermo Fisher Scientific Inc4.11%4.56%4.11%
Danaher Corp2.96%3.28%2.96%
Agilent Technologies Inc2.61%1.73%1.73%
Intuitive Surgical Inc2.43%3.07%2.43%
Stryker Corp2.22%2.16%2.16%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in TMED

  1. Gilead Sciences Inc — 4.44%
  2. Cencora Inc — 2.75%
  3. Alnylam Pharmaceuticals Inc — 2.60%
  4. Insulet Corp — 2.38%
  5. Dyne Therapeutics Inc — 2.03%
  6. Elanco Animal Health Inc — 1.91%
  7. Pfizer Inc — 1.91%
  8. Cytokinetics Inc — 1.69%
  9. Waters Corp — 1.68%
  10. West Pharmaceutical Services — 1.65%
  11. Ascendis Pharma A/s — 1.60%
  12. Biogen Inc — 1.55%
  13. Mckesson Corp — 1.46%
  14. Dexcom Inc — 1.46%
  15. Immunome Inc — 1.38%

Only in PHLAX

  1. Merck & Company Inc — 6.06%
  2. Argenx Se — 3.55%
  3. Vertex Pharmaceuticals Inc — 3.37%
  4. Lonza Group Ag — 3.02%
  5. Cvs Health Corp — 2.52%
  6. (PIPA070) PGIM Core Government Money Market Fund — 2.50%
  7. Insmed Inc — 2.28%
  8. Roivant Sciences Ltd — 2.21%
  9. Sionna Therapeutics Inc — 2.01%
  10. Beone Medicines Ltd — 1.82%
  11. Vaxcyte Inc — 1.77%
  12. Align Technology Inc — 1.75%
  13. Palvella Therapeutics Inc — 1.56%
  14. Apogee Therapeutics Inc — 1.42%
  15. Cabaletta Bio Inc — 1.35%

Asset mix

Asset typeTMEDPHLAX
Stocks99.3%97.8%
Cash & short-term funds0.7%3.8%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Country mix

CountryTMEDPHLAX
US93.3%84.7%
NL0.9%5.4%
CH0.5%4.8%
BM—2.2%
DK1.6%—
DE1.6%0.9%
GB—1.1%
KY1.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Check another pair

FAQ

How much do TMED and PHLAX overlap?
About 48% by weight. 7 securities appear in both funds' top 25 holdings; they make up 37.6% of TMED's assets and 38.0% of PHLAX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do TMED and PHLAX have in common?
The largest shared holdings are Eli Lilly & Co, Unitedhealth Group Inc, Thermo Fisher Scientific Inc, Danaher Corp, Intuitive Surgical Inc.
Should I own both TMED and PHLAX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, TMED or PHLAX?
TMED is broader, with 102 positions versus 55 for PHLAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.